Number of the records: 1  

Two Novel Semisynthetic Lipoglycopeptides Active against Staphylococcus aureus Biofilms and Cells in Late Stationary Growth Phase

  1. 1.
    SYSNO ASEP0550795
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleTwo Novel Semisynthetic Lipoglycopeptides Active against Staphylococcus aureus Biofilms and Cells in Late Stationary Growth Phase
    Author(s) Vimberg, Vladimír (MBU-M) ORCID
    Zieglerová, Leona (MBU-M) ORCID
    Mazumdar, Aninda (MBU-M)
    Szucs, Z. (HU)
    Borbas, A. (HU)
    Herczegh, P. (HU)
    Balíková Novotná, Gabriela (MBU-M) ORCID
    Article number1182
    Source TitlePharmaceuticals. - : MDPI
    Roč. 14, č. 11 (2021)
    Number of pages12 s.
    Languageeng - English
    CountryCH - Switzerland
    Keywordsantibiotic resistance ; glycopeptide antibiotics ; Staphylococcus aureus ; teicoplanin pseudoaglycon
    Subject RIVEE - Microbiology, Virology
    OECD categoryMicrobiology
    R&D ProjectsNV15-28807A GA MZd - Ministry of Health (MZ)
    ED1.1.00/02.0109 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    Method of publishingOpen access
    Institutional supportMBU-M - RVO:61388971
    UT WOS000726030300001
    EID SCOPUS85122064512
    DOI10.3390/ph14111182
    AnnotationThe increase in antibiotic resistance among Gram-positive bacteria underscores the urgent need to develop new antibiotics. New antibiotics should target actively growing susceptible bacteria that are resistant to clinically accepted antibiotics including bacteria that are not growing or are protected in a biofilm environment. In this paper, we compare the in vitro activities of two new semisynthetic glycopeptide antibiotics, MA79 and ERJ390, with two clinically used glycopeptide antibiotics-vancomycin and teicoplanin. The new antibiotics effectively killed not only exponentially growing cells of Staphylococcus aureus, but also cells in the stationary growth phase and biofilm.
    WorkplaceInstitute of Microbiology
    ContactEliška Spurná, eliska.spurna@biomed.cas.cz, Tel.: 241 062 231
    Year of Publishing2022
    Electronic addresshttps://www.mdpi.com/1424-8247/14/11/1182
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.